Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion type Assertion NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_head.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion description "[Three different human endometrial cancer cell lines known to have wild type PTEN (HEC 1-A) or a mutated inactive PTEN protein (RL 95-2 and Ishikawa) were used for these studies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion evidence source_evidence_literature NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion SIO_000772 15016316 NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion wasDerivedFrom befree-2016 NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.
- NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_assertion wasGeneratedBy ECO_0000203 NP435355.RAhj_CGocUI2TReOigAe-_d7atgu9o11qfor4hP-HnMbM130_provenance.